HomeTECH • NASDAQ
add
BIO-TECHNE Corp
Previous close
$76.06
Day range
$75.85 - $77.59
Year range
$51.79 - $89.91
Market cap
12.18B USD
Avg Volume
1.17M
P/E ratio
55.88
Dividend yield
0.41%
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 303.43M | 3.16% |
Operating expense | 137.60M | 11.61% |
Net income | 49.06M | -30.13% |
Net profit margin | 16.17 | -32.26% |
Earnings per share | 0.48 | -9.43% |
EBITDA | 94.50M | -10.73% |
Effective tax rate | 19.69% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 145.31M | -7.56% |
Total assets | 2.72B | 4.67% |
Total liabilities | 706.80M | -0.45% |
Total equity | 2.01B | — |
Shares outstanding | 157.31M | — |
Price to book | 5.94 | — |
Return on assets | 6.16% | — |
Return on capital | 6.68% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 49.06M | -30.13% |
Cash from operations | 80.99M | 60.26% |
Cash from investing | -16.44M | 93.18% |
Cash from financing | -52.42M | -134.75% |
Net change in cash | 9.78M | 126.16% |
Free cash flow | 54.73M | 73.13% |
About
Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. Wikipedia
Founded
1976
Headquarters
Website
Employees
3,200
